China Digest: Orient Speech Therapy bags $23m; Lightspeed invests in PrecisioNext

Orient Speech Therapy (OST) has pocketed $23 million in its Series C1 round of financing led by Cenova Capital, while PrecisioNext has closed its Series B round raising 100 million yuan ($15 million).